D. E. Shaw & Co. Inc. Sells 78,671 Shares of Owens & Minor, Inc. (NYSE:OMI)

D. E. Shaw & Co. Inc. trimmed its stake in shares of Owens & Minor, Inc. (NYSE:OMIFree Report) by 10.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 663,718 shares of the company’s stock after selling 78,671 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Owens & Minor were worth $8,675,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of OMI. Deutsche Bank AG grew its position in shares of Owens & Minor by 77.0% during the fourth quarter. Deutsche Bank AG now owns 495,111 shares of the company’s stock valued at $6,471,000 after purchasing an additional 215,455 shares in the last quarter. Cetera Investment Advisers purchased a new position in Owens & Minor during the 4th quarter valued at approximately $140,000. Brevan Howard Capital Management LP purchased a new position in Owens & Minor during the 4th quarter valued at approximately $246,000. Algert Global LLC increased its stake in Owens & Minor by 29.4% in the 4th quarter. Algert Global LLC now owns 357,789 shares of the company’s stock worth $4,676,000 after acquiring an additional 81,351 shares during the last quarter. Finally, Freestone Grove Partners LP purchased a new stake in shares of Owens & Minor during the 4th quarter worth approximately $5,125,000. 98.04% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

OMI has been the subject of a number of recent research reports. Robert W. Baird raised their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. UBS Group lowered their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. JPMorgan Chase & Co. reduced their target price on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a report on Monday, March 10th. Finally, Citigroup decreased their target price on shares of Owens & Minor from $13.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, April 17th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $12.50.

Get Our Latest Report on Owens & Minor

Insiders Place Their Bets

In other Owens & Minor news, major shareholder Coliseum Capital Management, L bought 160,000 shares of Owens & Minor stock in a transaction on Thursday, April 3rd. The shares were acquired at an average price of $8.53 per share, for a total transaction of $1,364,800.00. Following the completion of the purchase, the insider now directly owns 10,784,599 shares in the company, valued at approximately $91,992,629.47. This trade represents a 1.51% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders bought a total of 2,718,412 shares of company stock valued at $24,495,308 over the last 90 days. Insiders own 3.69% of the company’s stock.

Owens & Minor Stock Down 2.4%

NYSE OMI opened at $7.06 on Thursday. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a 52 week low of $6.07 and a 52 week high of $21.02. The firm has a market capitalization of $545.42 million, a price-to-earnings ratio of -10.86, a PEG ratio of 0.20 and a beta of 1.38. The company has a fifty day moving average of $7.96 and a two-hundred day moving average of $10.68.

Owens & Minor (NYSE:OMIGet Free Report) last released its earnings results on Saturday, May 10th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.03. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm’s revenue for the quarter was up .7% compared to the same quarter last year. During the same period last year, the firm posted $0.19 earnings per share. On average, analysts predict that Owens & Minor, Inc. will post 1.51 earnings per share for the current year.

Owens & Minor declared that its board has approved a share buyback program on Friday, February 28th that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the company to purchase up to 13.6% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

About Owens & Minor

(Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Further Reading

Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMIFree Report).

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.